Stock Analysis on Net
Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Intuitive Surgical Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Intuitive Surgical Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable
Accrued compensation and employee benefits
Deferred revenue
Other accrued liabilities
Current liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, $0.001 par value, issuable in series; zero shares issued and outstanding
Common stock, $0.001 par value
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Total Intuitive Surgical, Inc. stockholders’ equity
Noncontrolling interest in joint venture
Total stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The balance sheet exhibits a consistent expansion in both total liabilities and stockholders' equity over the analyzed period. Total liabilities and stockholders' equity increased from 11.54 billion USD in March 2021 to 20.88 billion USD by June 2026, representing a significant growth in the overall capital base.

Liabilities Trend Analysis
Current liabilities demonstrated a sustained upward trajectory, growing from 904.6 million USD in March 2021 to 1.92 billion USD in June 2026. This increase was primarily driven by growth in accounts payable, which nearly tripled, and a substantial rise in other accrued liabilities, which climbed from 248.6 million USD to 670.6 million USD. Accrued compensation and employee benefits also showed significant volatility and growth, peaking at 648.4 million USD in December 2025 before moderating.
Long-term liabilities remained relatively stable for the first half of the period but entered a growth phase starting in late 2024, increasing from 468.3 million USD in September 2024 to 656.0 million USD by June 2026.
Stockholders' Equity Composition
Total stockholders' equity grew from 10.19 billion USD in March 2021 to 18.30 billion USD in June 2026. A primary driver of this growth was the additional paid-in capital, which rose steadily from 6.63 billion USD to 11.33 billion USD, indicating a continuous infusion of capital or the impact of stock-based compensation.
Retained earnings exhibited a general upward trend, increasing from 3.51 billion USD to 6.84 billion USD, although this growth was marked by intermittent quarterly declines, most notably between June 2022 and March 2023, and again in early 2026.
Accumulated other comprehensive income showed high volatility, shifting from a positive 11.4 million USD in March 2021 to a low of negative 187.6 million USD in September 2022, before recovering to a positive balance in late 2024 and 2025.
Financial Solvency and Structure
The ratio of total liabilities to total stockholders' equity remained consistently low throughout the period. In March 2021, liabilities represented approximately 13.3% of equity; by June 2026, this ratio shifted slightly to approximately 14.1%. This indicates a highly equity-financed capital structure with minimal reliance on debt.
Deferred revenue increased from 358.1 million USD to 549.4 million USD, suggesting a growth in prepaid obligations and a potentially expanding pipeline of future revenue recognition.